Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Social Functioning in Schizophrenia
NCT03900754Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2020
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in schizophrenia, sponsored by VA Office of Research & Development. Started Jan 2020; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03900754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03900754.